| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | UNITED THERAPEUTICS CORP CMN | Feb 5, 2026 | |
| Sell | United Therapeutics Corporat | Oct 31, 2025 | |
| Buy | United Therapeutics Corporat | Oct 30, 2025 | |
| Sell | United Therapeutics Corporat | Oct 30, 2025 | |
| Sell | UNITED THERAPEUTICS CORP | Aug 22, 2025 | |
| Buy | UNITED THERAPEUTICS CORP | Aug 7, 2025 | |
| Sell | UNITED THERAPEUTICS CORP | Jun 27, 2025 | |
| Buy | United Therapeutics Corporat | Jun 11, 2025 | |
| Sell | UNITED THERAPEUTICS CMN | Feb 25, 2025 | |
| Sell | UNITED THERAPEUTICS CORP | Nov 20, 2024 |
This page tracks congressional stock trading activity in United Therapeutics Corporation (UTHR) in the Healthcare sector. Disclosed Capitol has indexed 46 disclosed congressional trades involving UTHR. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of March 2026 — Disclosed Capitol has tracked 46 disclosed congressional trades in United Therapeutics Corporation (UTHR) — 31:9 sell-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Feb 5, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Oct 31, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Oct 30, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| Oct 30, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Aug 22, 2025 | Michael McCaul | R | Sale | $1,001 - $15,000 |
| Aug 7, 2025 | Michael McCaul | R | Purchase | $15,001 - $50,000 |
| Jun 27, 2025 | Michael McCaul | R | Sale | $1,001 - $15,000 |
| Jun 11, 2025 | Lisa McClain | R | Buy | $1,001 - $15,000 |
| Feb 25, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Nov 20, 2024 | Michael McCaul | R | Exchange | $1,001 - $15,000 |
Across the 46 disclosed congressional trades in United Therapeutics Corporation (UTHR), members of Congress have reported 9 buys and 31 sells. The average 30-day alpha vs. the S&P 500 is -1.29%.
As of August 2026, corporate insiders at United Therapeutics Corporation have filed 888 SEC Form 4 transactions in UTHR over the past 12 months — including 1 open-market buy worth $864K and 776 sells worth $397.7M.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Option Exercise | $1.3M |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $253K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $329K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $361K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $62K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $124K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $145K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $104K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $522K |
| 2026-08-27 | ROTHBLATT MARTINE A — Chairperson & CEO | Sale | $249K |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
As of April 2026, United Therapeutics Corporation has 107 federal contract award records on file from USAspending.gov — most recently -$271K from the Department of Veterans Affairs on 2026-04-22.
| Award date | Agency | Amount |
|---|---|---|
| 2026-04-22 | Department of Veterans Affairs | -$271K |
| 2025-10-20 | Department of Veterans Affairs | $108K |
| 2025-10-14 | Department of Veterans Affairs | $379K |
| 2025-06-05 | Department of Veterans Affairs | -$90K |
| 2025-05-01 | Department of Veterans Affairs | -$88K |
| 2025-04-16 | Department of Veterans Affairs | -$73K |
| 2025-01-24 | Department of Veterans Affairs | -$73K |
| 2025-01-21 | Department of Veterans Affairs | $90K |
| 2024-10-08 | Department of Veterans Affairs | $88K |
| 2024-06-12 | Department of Veterans Affairs | $59K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, United Therapeutics Corporation reported revenue of $3.18B and net income of $1.33B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $783.3M, net income $333.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.